Amryt Pharma Competitors and Similar CompaniesClear all
Amryt Pharma's competitors and similar companies include UCB.
 Amryt Pharma Amryt Pharma is a specialty pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 2004 | Founding Date 1928 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Greater London, GB HQ Niefern öschelbronn, DE Dublin, IE Dublin, IE London, GB Boston, US Boston, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 182 | Employees 9,052 |
Financial | ||
Revenue (est.) | Revenue (est.) $222.5m (FY, 2021) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods $52.8m (FY, 2021) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit $169.8m (FY, 2021) | Gross profit €7.2b (FY, 2025) |
Net income | Net income $1m (FY, 2021) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company